$3.29
2.08% yesterday
Nasdaq, Jun 27, 10:00 pm CET
ISIN
US7163821066
Symbol
PETS

PetMed Express, Inc. Stock price

$3.29
-0.48 12.73% 1M
-1.87 36.24% 6M
-1.53 31.74% YTD
-0.89 21.29% 1Y
-18.71 85.05% 3Y
-29.97 90.11% 5Y
-13.85 80.81% 10Y
-3.97 54.71% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.07 2.08%
ISIN
US7163821066
Symbol
PETS
Industry

Key metrics

Basic
Market capitalization
$68.0m
Enterprise Value
$17.9m
Net debt
$-50.1m
Cash
$50.1m
Shares outstanding
20.7m
Valuation (TTM | estimate)
P/E
329.00 | 15.73
P/S
0.28 | 0.29
EV/Sales
0.07 | 0.08
EV/FCF
20.77
P/B
0.71
Dividends
DPS
$1.20
Yield 1Y | 5Y
36.47% | 4.19%
Growth 1Y | 5Y
0.00% | 7.14%
Payout 1Y | 3Y
12,000.00% | 136.96%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$247.0m | $234.8m
EBITDA
$8.4m | $4.1m
EBIT
$1.5m
Net Income
$360.0k | $4.3m
Free Cash Flow
$860.0k
Growth (TTM | estimate)
Revenue
-10.82% | -16.48%
EBITDA
226.97% | 472.61%
EBIT
111.94%
Net Income
104.45% | 157.91%
Free Cash Flow
-50.00%
Margin (TTM | estimate)
Gross
27.68%
EBITDA
3.39% | 1.76%
EBIT
0.62%
Net
0.14% | 1.84%
Free Cash Flow
0.35%
Financial Health
Equity Ratio
56.94%
Return on Equity
-7.72%
ROCE
1.57%
ROIC
0.34%
Debt/Equity
0.00
More
EPS
$0.01
FCF per Share
$0.04
Short interest
6.79%
Employees
287.00
Rev per Employee
$980.00k
Show more

Is PetMed Express, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

PetMed Express, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a PetMed Express, Inc. forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a PetMed Express, Inc. forecast:

Hold
43%
Sell
57%

Financial data from PetMed Express, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
247 247
11% 11%
100%
- Direct Costs 179 179
10% 10%
72%
68 68
12% 12%
28%
- Selling and Administrative Expenses 60 60
29% 29%
24%
- Research and Development Expense - -
-
-
8.38 8.38
227% 227%
3%
- Depreciation and Amortization 6.86 6.86
12% 12%
3%
EBIT (Operating Income) EBIT 1.52 1.52
112% 112%
1%
Net Profit 0.36 0.36
104% 104%
0%

In millions USD.

Don't miss a Thing! We will send you all news about PetMed Express, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PetMed Express, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) on behalf of PetMed stockholders. Our investigation concerns whether PetMed has violated the federal securities laws and/or engaged in other unlawful business practi...
Neutral
Business Wire
one day ago
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PETMED EXPRESS, INC. (PETS), C...
Neutral
Business Wire
2 days ago
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PETMED EXPRESS, INC. (PETS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CL...
More PetMed Express, Inc. News

Company Profile

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Head office United States
CEO Sandra Campos
Employees 287
Founded 1996
Website www.1800petmeds.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today